A clinical specification for a randomized clinical trial on lithium in amyotrophic lateral sclerosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 25, 2008, Pages

  Vanacore, Nicola ^a   Galeotti, Francesca ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; RILUZOLE;

ALTERNATIVE MEDICINE; AMYOTROPHIC LATERAL SCLEROSIS; AUTHOR; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SURVIVAL RATE; THERAPY EFFECT;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; HUMANS; LITHIUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL CORD;

EID: 47249148801     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801837105     Document Type: Letter

References (2)

1. Fornai F, et al. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 105:2052-2057.
2. Groeneveld GJ, Graf M, van derTweel I, van den Berg LH, Ludolph AC (2007) Alternative trial design in amyotrophiclateral sclerosis saves time and patients. Amyotroph Lateral Scler 8:266-269.